Skip to content
2000
Volume 6, Issue 3
  • ISSN: 1573-4021
  • E-ISSN: 1875-6506

Abstract

Prostaglandin E2 (PGE2) participates in blood pressure (BP) regulation through diverse mechanisms involving different tissues and different receptor subtypes. In general, PGE2 functions as a natriuretic factor in the kidney, promoting sodium excretion via inhibition of sodium transport in the distal nephron. On the other hand, PGE2 is a vasoactive agent capable of modulating vascular tone. PGE2 is a product of prostaglandin E synthase (PGES) and its biologic action is mediated by four EP receptors EP1-4 which exhibit distinct vasoactive properties. The best characterized PGES is microsomal prostaglandin E synthase-1 (mPGES-1), a viable target for the next generation of analgesic drugs. The review will focus on recent advances in understanding the roles of mPGES-1 and EP receptors in BP regulation.

Loading

Article metrics loading...

/content/journals/chyr/10.2174/157340210791936741
2010-08-01
2025-09-14
Loading full text...

Full text loading...

/content/journals/chyr/10.2174/157340210791936741
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test